Ftse Mib
34.274,33
-0,30%
DAX
18.501,04
-0,53%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.171,75
-2,59%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
03/03/201615:00PR Newswire (US)BioPharmX commences Phase 2 clinical study under U.S. FDA IND for BPX-01AMEX:BPMXBioPharmX Corporation
25/02/201618:30PR Newswire (US)BioPharmX Announces Therapeutic Dermatology Advisory BoardAMEX:BPMXBioPharmX Corporation
16/02/201615:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
05/02/201612:02Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
01/02/201615:00PR Newswire (US)BioPharmX Appoints Marie-Louise Bots as Senior VP of Corporate DevelopmentAMEX:BPMXBioPharmX Corporation
27/01/201620:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
27/01/201620:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
27/01/201615:03Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
27/01/201615:00PR Newswire (US)BioPharmX Corporation Appoints Craig A. Barbarosh to its Board of DirectorsAMEX:BPMXBioPharmX Corporation
19/01/201614:32Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BPMXBioPharmX Corporation
15/01/201615:00PR Newswire (US)Study Shows Topical BioPharmX Formulation Treats Acne While Minimizing Systemic Exposure of MinocyclineAMEX:BPMXBioPharmX Corporation
12/01/201614:00PR Newswire (US)BioPharmX Violet Iodine Mobile Marketing Campaign On Pandora Achieves 25 Times the Average Industry ResponseAMEX:BPMXBioPharmX Corporation
21/12/201519:41Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BPMXBioPharmX Corporation
15/12/201519:04Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
14/12/201522:05PR Newswire (US)BioPharmX Corporation Reports Third Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
11/12/201515:00PR Newswire (US)BioPharmX Corporation to Report Third Quarter Financial Results on December 14, 2015AMEX:BPMXBioPharmX Corporation
11/12/201514:00PR Newswire (US)Study Shows Safety of BioPharmX Topical FormulationAMEX:BPMXBioPharmX Corporation
10/12/201522:10PR Newswire (US)BioPharmX Corporation Closes Direct InvestmentAMEX:BPMXBioPharmX Corporation
10/11/201514:00PR Newswire (US)BioPharmX Corporation to Offer Violet Iodine Supplement in over 3,000 General Nutrition Center (GNC) StoresAMEX:BPMXBioPharmX Corporation
04/11/201514:00PR Newswire (US)Study Shows BioPharmX Formulation Offers More Effective Acne Treatment by Targeted Delivery of MinocyclineAMEX:BPMXBioPharmX Corporation
29/10/201513:00PR Newswire (US)BioPharmX Corporation Names AnnaMarie Daniels Executive Vice President of Clinical and Regulatory AffairsAMEX:BPMXBioPharmX Corporation
14/10/201514:00PR Newswire (US)Study Shows Novel BioPharmX Formulation Promises Breakthrough in Acne TreatmentAMEX:BPMXBioPharmX Corporation
29/09/201515:00PR Newswire (US)BioPharmX Corporation Expands Management Team to Support Growth and Market ExpansionAMEX:BPMXBioPharmX Corporation
22/09/201513:30PR Newswire (US)Survey Shows Most U.S. Women Suffer from Premenstrual Breast DiscomfortAMEX:BPMXBioPharmX Corporation
14/09/201522:05PR Newswire (US)BioPharmX Corporation Reports Second Quarter ResultsAMEX:BPMXBioPharmX Corporation
09/09/201514:00PR Newswire (US)BioPharmX Corporation to Release Second Quarter 2016 Financial ResultsAMEX:BPMXBioPharmX Corporation
02/09/201514:00PR Newswire (US)BioPharmX Corporation To Present at Rodman & Renshaw 17th Annual Global Investment ConferenceAMEX:BPMXBioPharmX Corporation
12/08/201514:00PR Newswire (US)Seasoned Silicon Valley Financial Executive Joins BioPharmX Corporation As Chief Financial OfficerAMEX:BPMXBioPharmX Corporation
28/07/201514:00PR Newswire (US)BioPharmX Corporation Launches Grocery Store Distribution of Violet® Iodine at Kroger SubsidiaryAMEX:BPMXBioPharmX Corporation
17/07/201514:00PR Newswire (US)BioPharmX Corporation Launches #HugsShouldntHurt Social Media CampaignAMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
FBK
Finecobank
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
ENI
Eni
BIT
BC
Brunello Cucinelli
BIT
PRY
Prysmian
BIT
SPM
Saipem
BIT
G
Generali
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network